Hospitais Proadi-SUS
PROADI-SUS is a Brazilian public health program, established in 2009 and governed by Complementary Law No. 187/2021, that channels tax contributions from seven private reference hospitals into SUS capacity-building, clinical research, telemedicine, and AI-enabled healthcare projects nationwide.
- Company typePrivate
- Founded2009
- HeadquartersSão Paulo, Brazil
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Hospitais Proadi-SUS does
PROADI-SUS (Programa de Apoio ao Desenvolvimento Institucional do Sistema Único de Saúde) is a Brazilian public health development program established in 2009 and formalized under Complementary Law No. 187 of December 16, 2021. It operates as a structured alliance between the Brazilian Ministry of Health and seven private nonprofit reference hospitals — A.C. Camargo Cancer Center, Hospital Alemão Oswaldo Cruz, BP - Beneficência Portuguesa de São Paulo, Hcor, Hospital Israelita Albert Einstein, Hospital Moinhos de Vento, and Hospital Sírio-Libanês. The program operates in three-year project cycles (triênios 2021-2023 and 2024-2026) and is funded through a tax exemption mechanism: participating hospitals redirect PIS, COFINS, and employer INSS contributions to projects that strengthen the Brazilian public health system (SUS), rather than withdrawing resources from healthcare.
The program delivers a portfolio of projects across clinical research (CAR-T cell therapy, flu vaccine studies), telemedicine (TeleUTI, TeleAME, TeleNordeste), healthcare management (Lean nas Emergências, PlanificaSUS, Hospital Qualification), specialized care (congenital heart disease, organ transplantation, palliative care), cancer screening networks (Detecta APS, Super Centro Brasil), patient safety (Saúde em Nossas Mãos), and AI-enabled platforms (Banco de Imagens Algoritmos, PAMDAS, DIAna). PROADI-SUS does not generate commercial revenue — services are delivered at no cost to patients or the government, and the program coordinates national reach across all Brazilian regions including remote indigenous communities, with measurable outcomes including an 81.7% reduction in maternal mortality in selected Amazonian municipalities and training of more than 7,700 healthcare professionals.
Hospitais Proadi-SUS firmographics
Firmographics- Name
- Hospitais Proadi-SUS
- Legal name
- PROADI-SUS (Programa de Apoio ao Desenvolvimento Institucional do Sistema Único de Saúde)
- Website
- https://hospitais.proadi-sus.org.br
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- PROADI-SUS is a Brazilian public health program, established in 2009 and governed by Complementary Law No. 187/2021, that channels tax contributions from seven private reference hospitals into SUS capacity-building, clinical research, telemedicine, and AI-enabled healthcare projects nationwide.
- Ownership category
- akta.pro rank
Hospitais Proadi-SUS industry classification
Industry- Product category
- Public Health Development Services
- NAICS
- Administration of Public Health Programs (923120), General Medical and Surgical Hospitals (6221), Public Administration (92)
- SIC
- Services-Hospitals (8060), Services-Health Services (8000), Services-General Medical & Surgical Hospitals, Nec (8062)
- akta.pro primary industry
- Health Systems Strengthening & Primary Care Development (HLAJAKAJ)
- akta.pro secondary industries
- Health Systems Strengthening & Global Health Technical Assistance (BPADAEAH), International & Global Public Health Aid Administration (Government Donors) (HLAJALAO), Monitoring, Evaluation, Research & Learning (MERL) for Global Health (BPADAIAO), Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)
Keywords
Where Hospitais Proadi-SUS is headquartered
LocationHeadquarters
- HQ city
- São Paulo
- HQ country
- Brazil
- HQ region
- Latin America
Offices7 records
Markets served
Hospitais Proadi-SUS business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Others
Revenue model
- Tax Exemption Reinvestment (Imunidade Fiscal): PROADI-SUS does not withdraw resources from healthcare. Projects are managed with resources from participating hospitals themselves, which qualify for tax immunity. Institutions pay amounts corresponding to certain taxes (PIS, COFINS, and employer contribution to INSS) and apply them to projects that effectively impact SUS development. The program is governed by Complementary Law No. 187 of December 16, 2021.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels4 records
Hospitais Proadi-SUS product offering
Product offeringCore offering
PROADI-SUS (Programa de Apoio ao Desenvolvimento Institucional do Sistema Único de Saúde) is a Brazilian public health program, established in 2009, that coordinates projects executed by seven leading private reference hospitals (A.C. Camargo Cancer Center, Hospital Alemão Oswaldo Cruz, BP, Hcor, Hospital Israelita Albert Einstein, Hospital Moinhos de Vento, and Hospital Sírio-Libanês) in partnership with the Ministry of Health. The program delivers capacity building, clinical research, health technology assessment, telemedicine services, hospital management programs, and specialized medical assistance to strengthen Brazil's public health system (SUS). Projects are funded through tax immunity mechanisms where participating hospitals redirect PIS, COFINS, and employer INSS contributions into SUS development projects.
Product overview
PROADI-SUS (Programa de Apoio ao Desenvolvimento Institucional do Sistema Único de Saúde) is a collaborative healthcare development program established in 2009, connecting six reference hospitals in Brazil with the Ministry of Health. The program operates through multiple interconnected initiatives including clinical research programs (CAR-T cell therapy, flu vaccine studies), telemedicine services (TeleUTI, TeleAMES, TeleNordeste), healthcare management initiatives (Lean nas Emergências, PlanificaSUS, Hospital Qualification), specialized care programs (congenital heart disease, organ transplants, palliative care), patient safety (Saúde em Nossas Mãos), cancer screening networks (Detecta APS, Super Centro Brasil), and AI-enabled platforms (Banco de Imagens Algoritmos, PAMDAS, DIAna). The portfolio also includes emergency response (Cidade Cardio-Protegida), indigenous health services, education programs (Ethics Committee training, EAD courses), and environmental health research (VERACIS, Vigiambsi).
Differentiator
Problem solved
Functional benefit
Products and services
- CAR-T Cell Development Project Phase I clinical study developing autologous CAR-T cells genetically modified to express chimeric antigen receptor targeting CD19 for treatment of B-cell malignancies, using closed-system semi-automated scalable manufacturing under GMP conditions. Executed by Hospital Israelita Albert Einstein for the SUS.
- Cardiofetal Congênito (Congenital Heart Disease Training and Care) Training and specialized healthcare for congenital heart diseases from fetus to adolescent, integrating fetal cardiology, pediatric cardiology, medical consulting, and second opinion services via telemedicine. Coordinated by Hcor with Instituto Nacional de Cardiologia and the CNRAC referral system to serve approximately 29,800 children born annually with congenital heart defects in Brazil.
- Cidade Cardio-Protegida (Heart-Safe City) Training of volunteer first responders and deployment of automated external defibrillators (AEDs) for cardiac arrest response, using a GPS-based mobile app for volunteer recruitment integrated with SAMU Porto Alegre emergency regulation system. Deployed 145 public AEDs and trained 1,900+ volunteers.
- Lean nas Emergências (Lean in Emergencies) Application of Toyota Production System Lean philosophy to combat overcrowding and optimize patient flow in Brazilian public health emergency units, using DMAIC (Define, Measure, Analyze, Implement, Control) methodology with visual management tools and case studies.
- Detecta APS (Early Detection in Primary Care) Qualification of early cancer detection in primary care through healthcare professional training, screening expansion with new technologies, and digital pathology networks. Trained 7,700+ healthcare professionals, executed by Hospital Alemão Oswaldo Cruz and Einstein Hospital Israelita.
- Super Centro Brasil (Super Center Brazil for Cancer Diagnosis) National diagnostic network in pathological anatomy using telemedicine, with capacity for 1,000 reports per day and 400,000 exams per year, created by A.C. Camargo Cancer Center with goal of reducing average diagnosis time from 25 to 5 days.
- PlanificaSUS Healthcare organization strategy strengthening prenatal care and integration between different levels of care in primary care settings. Implemented by Hospital Israelita Albert Einstein across Baixo Amazonas municipalities (Parintins, Maués, Boa Vista do Ramos, Barreirinha, Nhamundá), achieving 81.7% maternal mortality reduction between 2018-2024.
- TeleUTI Brasil (Tele-ICU Brazil) Intensive care qualification through telemedicine, connecting remote hospitals to specialist teams for patient monitoring and clinical decision support in ICU settings.
- TeleAMES (Specialized Medical Assistance in North/Central-West) Specialized medical assistance in North and Central-West Brazil via telemedicine, connecting remote Basic Health Units to specialist centers.
- TeleNordeste Collaborative telemedicine project providing specialized medical assistance in Northeast Brazil.
- Saúde em Nossas Mãos (Health in Our Hands) Reducing healthcare-associated infections in Brazilian public hospital units through quality improvement and patient safety practices.
- Indigenous Health Program Healthcare services for indigenous populations in isolated regions including prenatal care, sanitation training, and teleconsultations across 34 Special Indigenous Sanitary Districts, serving 24,000+ indigenous people.
- Qualificação Hospitalar (Hospital Qualification) Hospital qualification programs across multiple hospitals (Hcor, Beneficência Portuguesa) focusing on emergency care, cardiac care, and healthcare worker training.
- Educa CEP (Research Ethics Committee Education) Continuing education for Research Ethics Committees to strengthen Brazil's CEP/CONEP system, provided by Hospital Moinhos de Vento.
- Banco de Imagens Algoritmos (Image Bank Algorithms) Validation of AI algorithms for chest X-ray, dermatology, and neurology analysis as part of medical imaging platform development at Einstein Hospital.
- Cuidados Paliativos (Palliative Care) Palliative care program in SUS across hospital, outpatient, and specialized settings, developed by Hospital Sírio-Libanês.
- Transplantar Organ and tissue donation and transplantation process qualification including intestinal rehabilitation and liver/intestinal multivisceral transplant services.
- Mais TMO (Bone Marrow Transplant) Bone marrow transplant program qualification in SUS, implemented by multiple hospitals including Beneficência Portuguesa and Hospital Moinhos de Vento.
- Sepse (Sepsis) Early identification and treatment of sepsis in emergency units through healthcare professional training.
- Brasilia Cord (Umbilical Cord Blood Bank) Cryopreservation and storage support for umbilical cord and placental blood for public use, collaborative project across multiple hospitals.
- PAMDAS (Health Data Auditing Platform) Data auditing and monitoring platform in healthcare for quality control and regulatory compliance.
- DIAna (National Health Data Network) Evolution and strengthening of the national health data network with emphasis on data science, developed by Einstein Hospital.
- HPV Vaccination and Screening HPV vaccination coverage expansion and cervical cancer early detection programs through healthcare worker training and digital diagnostic networks.
- Flu Vaccine Study (VIP) Clinical study evaluating influenza vaccine efficacy for reducing mortality and hospitalizations, including dual-dose strategy for stroke patients showing up to 20% reduction in death and hospitalization risk.
- VERACIS (Ethnic-Racial Vulnerabilities) Study on ethnic-racial vulnerabilities, environment, climate and health impacts including Bolsa Família population analysis.
- Vigiambsi (Indigenous Environmental Surveillance) Environmental surveillance and indigenous health monitoring program.
- Telescope II (Telemedicine Impact) Clinical impact assessment of different telemedicine practices in ICU units.
Quantifiable outcome
- 81.7% reduction in maternal mortality in Baixo Amazonas municipalities (2018-2024)
- +6 more outcomes
Companies that use Hospitais Proadi-SUS
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles4 records
Hospitais Proadi-SUS technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature5 records
Hospitais Proadi-SUS partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered flagship, core and minor.
- Brazilian Ministry of HealthflagshipPrimary government partner in the PROADI-SUS alliance. The Ministry of Health establishes program priorities and receives institutional support through projects developed jointly with participating hospitals. Governed by Complementary Law No. 187 of December 16, 2021.
- A.C. Camargo Cancer CentercoreReference hospital specializing in oncology participating in PROADI-SUS. Executes cancer-related projects including Super Centro Brasil diagnostic network and cervical cancer detection initiatives.
- Hospital Alemão Oswaldo Cruz (HAOC)coreReference hospital participating in PROADI-SUS with focus on health technology assessment, data science, pharmaceutical assistance, and health surveillance projects.
- BP - Beneficência Portuguesa de São PaulocoreReference hospital participating in PROADI-SUS, executing projects including Tele-UTI Brasil, bone marrow transplantation, and health surveillance initiatives.
- Hcor (Hospital do Coração)coreReference hospital specializing in cardiology participating in PROADI-SUS. Executes congenital heart disease, cardiovascular best practices, and health technology assessment projects.
- Hospital Israelita Albert Einstein (HIAE)coreLeading reference hospital participating in PROADI-SUS, executing projects spanning CAR-T cell therapy, PlanificaSUS, telemedicine, health technology assessment, and vaccine research.
- Hospital Moinhos de Vento (HMV)coreReference hospital participating in PROADI-SUS with focus on telemedicine (TeleUTI, Teleoftalmo), clinical research, patient safety, and healthcare professional training.
- Hospital Sírio-Libanês (HSL)coreReference hospital participating in PROADI-SUS, executing projects including sepsis treatment, palliative care, organ transplantation, and clinical trials.
- Conselho Nacional de Secretários de Saúde (CONASS)coreNational council of health secretaries partnering with PROADI-SUS for project development and implementation, particularly for PlanificaSUS strategy in maternal health.
- Farmácias Panvel and Farmácias São JoãominorPharmacy chains in Porto Alegre partnering to host 145 public AEDs (Automated External Defibrillators) for the Cidade Cardio-Protegida cardiac emergency response network.
- Instituto Nacional de Cardiologia (INC)coreNational Cardiology Institute partnering with Hcor for congenital heart disease project, coordinating technical chamber for RENASCE (National Specialized Cardiovascular Health Network).
- Central Nacional de Regulação de Alta Complexidade (CNRAC)coreNational referral system for high-complexity care managing patient flow for congenital heart disease treatment, ensuring proper case classification and treatment prioritization.
Scale indicators9 records
Recent moves6 records
Expansion highlights6 records
Hospitais Proadi-SUS competitors and assessment
Company assessmentDirect peers
- Hospital Moinhos de Vento: Participating reference hospital based in Porto Alegre, executing TeleUTI, Teleoftalmo, clinical research, and healthcare training projects within PROADI-SUS. Comparable as alliance partner with telemedicine and research focus.
- BP - Beneficência Portuguesa de São Paulo: Participating reference hospital and program coordinator, leading TeleUTI Brasil, bone marrow transplantation, and health surveillance projects. Comparable as alliance partner and administrative coordinator.
- Hospital Israelita Albert Einstein: One of the seven participating reference hospitals and the lead executor of flagship PROADI-SUS projects including CAR-T cell therapy, PlanificaSUS, and AI medical imaging. Comparable as a top-tier Brazilian nonprofit hospital with deep involvement in the PROADI-SUS alliance.
- Hospital Alemão Oswaldo Cruz: Participating reference hospital executing health technology assessment, data science, and pharmaceutical assistance projects. Comparable as alliance partner with HTA focus.
- Hospital Sírio-Libanês: Participating reference hospital executing PROADI-SUS projects in sepsis, palliative care, organ transplantation, and clinical trials. Comparable as a leading São Paulo-based nonprofit hospital within the same alliance.
- Hcor - Hospital do Coração: Participating reference hospital specializing in cardiology, executing congenital heart disease and cardiovascular projects (CNRAC/RENASCE). Comparable as cardiology-specialized alliance partner.
- A.C. Camargo Cancer Center: Participating reference hospital leading the Super Centro Brasil cancer diagnostic network and HPV/cervical cancer screening initiatives under PROADI-SUS. Comparable as oncology-specialized alliance member.
Broad incumbents
- NHS England: Public health system administrator overseeing capacity building, technology incorporation, and quality improvement across England's universal healthcare system. Comparable in the public-administration-of-health-systems role, though at vastly larger scale.
Emerging players
- GAVI, the Vaccine Alliance: Global public-private health alliance funding immunization and health systems strengthening in lower- and middle-income countries. Comparable as a multi-stakeholder alliance channeling private and public resources into health system development, though globally focused.
- The Global Fund to Fight AIDS, Tuberculosis and Malaria: Multilateral financing mechanism channeling public-private resources into health system strengthening and disease-specific programs in developing countries. Comparable as a structured public-private health development model with project cycles and measurable outcomes.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Hospitais Proadi-SUS social profiles
Digital presenceHospitais Proadi-SUS financial estimates
Financial estimateRevenue estimate
Valuation estimate
Hospitais Proadi-SUS leadership team
Management profileNumber of profiles
Hospitais Proadi-SUS subsidiaries and ownership
Company hierarchySubsidiaries7 records
Hospitais Proadi-SUS funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Hospitais Proadi-SUS M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Hospitais Proadi-SUS
What does Hospitais Proadi-SUS do?
PROADI-SUS (Programa de Apoio ao Desenvolvimento Institucional do Sistema Único de Saúde) is a Brazilian public health program, established in 2009, that coordinates projects executed by seven leading private reference hospitals (A.C. Camargo Cancer Center, Hospital Alemão Oswaldo Cruz, BP, Hcor, Hospital Israelita Albert Einstein, Hospital Moinhos de Vento, and Hospital Sírio-Libanês) in partnership with the Ministry of Health. The program delivers capacity building, clinical research, health technology assessment, telemedicine services, hospital management programs, and specialized medical assistance to strengthen Brazil's public health system (SUS). Projects are funded through tax immunity mechanisms where participating hospitals redirect PIS, COFINS, and employer INSS contributions into SUS development projects.
Is Hospitais Proadi-SUS a public or private company?
Hospitais Proadi-SUS is a private company. It is classified as state government owned and is currently operating.
When was Hospitais Proadi-SUS founded?
Hospitais Proadi-SUS was founded in 2009. It employs 101 to 250 people.
Where is Hospitais Proadi-SUS based?
Hospitais Proadi-SUS is headquartered in São Paulo, Brazil, in the Latin America region.
How does Hospitais Proadi-SUS make money?
One revenue line is on record: tax Exemption Reinvestment (Imunidade Fiscal).
Who are Hospitais Proadi-SUS's main competitors?
Direct peers on record are Hospital Moinhos de Vento, BP - Beneficência Portuguesa de São Paulo, Hospital Israelita Albert Einstein, Hospital Alemão Oswaldo Cruz, Hospital Sírio-Libanês, Hcor - Hospital do Coração and A.C. Camargo Cancer Center. NHS England is listed as a broad incumbent. Emerging players are GAVI, the Vaccine Alliance and The Global Fund to Fight AIDS, Tuberculosis and Malaria.
Does Hospitais Proadi-SUS have an API?
No public API is recorded for Hospitais Proadi-SUS.
What industry is Hospitais Proadi-SUS in?
Hospitais Proadi-SUS's product category is Public Health Development Services. Its primary akta.pro industry code is HLAJAKAJ, Health Systems Strengthening & Primary Care Development, with a secondary code of BPADAEAH, Health Systems Strengthening & Global Health Technical Assistance. Its NAICS code is 923120 and its SIC code is 8060.